Aaron Siri: Someone inside Kaiser sent me the below internal guidance concerning shots and medications for newborns. It tells Kaiser employees that the “approach to how we introduce and administer routine newborn … Hepatitis B vaccine” is to “avoid saying ‘it’s optional’ or ‘you can refuse’ unless directly asked” and to tell parents that “we will be giving” instead of asking consent to give. This is the antithesis of informed consent. Yet Kaiser calls it “excellent patient and family care.”

Elephant on the sofa: Spanish doctor warns of the increase in cancer cases and immune health issues as a result of ‘Covid’ [fake] vaccines. Dr. Luis Miguel Benito de Benito, a specialist in the digestive system, exposes the reality when so many stay silent about the bloody obvious. He denounces the rise in hematological and digestive tumors, especially in the young, and the appearance of so-called ‘turbo cancers’. Dr. Benito directly points to the ‘Covid’ [fake] vaccines as a factor contributing to the deterioration of the immune system, stating that what many colleagues discuss in private must now be said publicly. He explains the worrying lack of response to current treatments and the institutional fear of acknowledging that the mass [fake] vaccination may have been a medical atrocity (which it was and is). He challenges official bodies to refute his clinical evidence with data.

A massive reproducibility project in Brazil found that only 15–45% of biomedical studies could be replicated. When RT-PCR and rodent models—the literal bread and butter of life sciences—fail to validate at this scale, the “gold standard” is looking more like tinfoil. If the majority of scientific publications cannot be reproduced or replicated, science doesn’t just have a technical problem—it has a trust problem.

Sources: 2. https://elifesciences.org/interviews/388d5959/brazilian-reproducibility-initiative For more on why we cannot “trust the science:” https://viroliegynewsletter.substack.com/p/trust-the-science

Forensic analysis of the 38 deaths of trial participants in the 6-month interim report on the clinical trial of the Pfizer/BioNTech mRNA vaccine BNT162b2: “In summary, it can be said that the decision by the US FDA and other international regulatory authorities to authorise the mRNA vaccine BNT162b2 was not a well-founded decision based on an unbiased, thorough and transparent assessment of the evidence intended to demonstrate that this vaccine meets the criteria for a ‘safe and effective’ tool for combating the COVID-19 pandemic.”

https://www.preprints.org/manuscript/202309.0131